This ebulletin contains informationonregulating biocides in Northern Ireland

Having trouble viewing this email?View the content as a web page.

Health and Safety Executive logo

HSE ebulletin

New EU active substance non-renewal decision

Biocidal products must be phased off the NI market

Following evaluation under the EU BPR, a decision has been taken not to renew the following active substance approval. This affects NI:

Along with the non-renewal, Implementing Decision (EU) 2023/1423 repeals the previous decision on the postponement of the expiry date for acrolein.

If you hold an affected EU BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision.

If you are aware of any disproportionate negative impacts that are likely to arise from the non-renewal of any of the active substance/product type combinations listed above, please contact us.


New EU active substance approval decisions

Apply for product authorisation by the deadline to keep your products on the NI market

Following evaluation under the EU BPR, a decision has been taken to approve the following active substance/product type combinations. This will affect NI:

Action for biocidal product suppliers

If you supply biocidal products containing these active substances in the relevant product types, you must apply for EU BPR product authorisation by 1 February 2025 to keep them on the NI market. New products (including new trade names) must not be supplied in NI until product authorisation is granted.

Action for active substance suppliers

If you supply these active substances for use in biocidal products of the relevant product types, you may need to apply for technical equivalence. If you havent demonstrated technical equivalence for your manufacturing source, EU BPR product authorisation cannot be granted for biocidal products containing your active substance.


Upcoming EU active substance approval dates

Apply for product authorisation by the deadlines to keep your products on the NI market

The following EU BPR active substance approval dates are coming up:

  • L-(+)-lactic acid (CAS 79-33-4 EC 201-196-2) in product type 06
    1 November 2023

  • Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents (CAS 89997-63-7 EC 289-699-3) in product type 19
    1 February 2024

  • Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical CO2 (CAS 89997-63-7 EC 289-699-3) in product type 19
    1 February 2024

  • N,N-Didecyl-N,N-dimethylammonium chloride (Didecyldimethylammonium chloride) (DDAC) (CAS 7173-51-5 EC 230-525-2) in product types 01 and 02
    1 February 2024

If you supply biocidal products containing these active substances in the relevant product types, dont forget to apply for EU BPR product authorisation by the dates above to keep them on the Northern Ireland market.

Get latest news and updates from HSE across a range of industries and topics bysubscribing to our ebulletins

GovUK footer logo

Health and Safety Executive - 5N1 Redgrave Court, Merton Road, Bootle, Merseyside L20 7HS